Susquehanna International Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-11,504
| Closed | -$39K | – | 14184 |
|
|
2025
Q2 | $39K | Sell |
11,504
-403
| -3% | -$1.34K | ﹤0.01% | 12179 |
|
|
2025
Q1 | $34.6K | Buy |
+11,907
| New | +$35.1K | ﹤0.01% | 11974 |
|
|
2024
Q3 | – | Sell |
-13,613
| Closed | -$62.1K | – | 13243 |
|
|
2024
Q2 | $62.1K | Buy |
+13,613
| New | +$104K | ﹤0.01% | 11321 |
|
|
2022
Q3 | – | Sell |
-1,890
| Closed | -$36.2K | – | 14280 |
|
|
2022
Q2 | $37K | Sell |
1,890
-286
| -13% | -$7.16K | ﹤0.01% | 12135 |
|
|
2022
Q1 | $79K | Sell |
2,176
-1,696
| -44% | -$61K | ﹤0.01% | 12066 |
|
|
2021
Q4 | $138K | Sell |
3,872
-254
| -6% | -$13.4K | ﹤0.01% | 11888 |
|
|
2021
Q3 | $309K | Buy |
4,126
+1,328
| +47% | +$94.3K | ﹤0.01% | 10535 |
|
|
2021
Q2 | $245K | Sell |
2,798
-612
| -18% | -$58.2K | ﹤0.01% | 11186 |
|
|
2021
Q1 | $389K | Buy |
+3,410
| New | +$378K | ﹤0.01% | 10044 |
|
|
2019
Q4 | – | Sell |
-161
| Closed | -$15K | – | 10815 |
|
|
2019
Q3 | $17K | Buy |
+161
| New | +$34.9K | ﹤0.01% | 9966 |
|
|
2019
Q2 | – | Sell |
-678
| Closed | -$239K | – | 10945 |
|
|
2019
Q1 | $315K | Buy |
678
+354
| +109% | +$137K | ﹤0.01% | 7127 |
|
|
2018
Q4 | $95K | Buy |
324
+71
| +28% | +$17K | ﹤0.01% | 8248 |
|
|
2018
Q3 | $44K | Sell |
253
-183
| -42% | -$33.6K | ﹤0.01% | 8881 |
|
|
2018
Q2 | $85K | Sell |
436
-303
| -41% | -$55.9K | ﹤0.01% | 9104 |
|
|
2018
Q1 | $108K | Buy |
739
+546
| +283% | +$107K | ﹤0.01% | 8670 |
|
|
2017
Q4 | $46K | Sell |
193
-77
| -29% | -$16K | ﹤0.01% | 8931 |
|
|
2017
Q3 | $55K | Buy |
+270
| New | +$49.7K | ﹤0.01% | 8520 |
|
|
2017
Q2 | – | Sell |
-509
| Closed | -$153K | – | 9946 |
|
|
2017
Q1 | $153K | Buy |
+509
| New | +$150K | ﹤0.01% | 8184 |
|
|
2016
Q1 | – | Sell |
-243
| Closed | -$109K | – | 9777 |
|
|
2015
Q4 | $109K | Buy |
243
+228
| +1,520% | +$143K | ﹤0.01% | 8841 |
|
|
2015
Q3 | $13K | Sell |
15
-26
| -63% | -$37.8K | ﹤0.01% | 9529 |
|
|
2015
Q2 | $116K | Sell |
41
-813
| -95% | -$3.43M | ﹤0.01% | 9617 |
|
|
2015
Q1 | $4.58M | Buy |
854
+851
| +28,367% | +$4.88M | ﹤0.01% | 2863 |
|
|
2014
Q4 | $19K | Buy |
+3
| New | +$25.2K | ﹤0.01% | 9484 |
|
|
2014
Q2 | – | Sell |
-2
| Closed | -$18K | – | 10170 |
|
|
2014
Q1 | $18K | Buy |
+2
| New | +$25.8K | ﹤0.01% | 8793 |
|
Other funds holding CSCI
Susquehanna International Group's CSCI Position: Q3 2025 in Review
Susquehanna International Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 11,504 shares — an estimated $39K sold.
Susquehanna International Group first reported a position in CSCI in Q1 2014 and held it in 24 quarters. The position peaked at $4.58M in Q1 2015. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.
- Susquehanna International Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 11,504 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $39K.
- Susquehanna International Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2014 and held it in 24 quarters.
- Susquehanna International Group's COSCIENS Biopharma Inc. Common Stock position peaked at $4.58M in Q1 2015.
- 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.